These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 32317280

  • 1. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
    Lee CAA, Banerjee P, Wilson BJ, Wu S, Guo Q, Berg G, Karpova S, Mishra A, Lian JW, Tran J, Emmerich M, Murphy GF, Frank MH, Frank NY.
    J Biol Chem; 2020 May 29; 295(22):7774-7788. PubMed ID: 32317280
    [Abstract] [Full Text] [Related]

  • 2. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 29; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

  • 3. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS, Harford JB, Moghe M, Rait A, Pirollo KF, Chang EH.
    Nucleic Acids Res; 2018 Feb 16; 46(3):1424-1440. PubMed ID: 29202181
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway.
    Lan Y, Lou J, Hu J, Yu Z, Lyu W, Zhang B.
    Cancer Biol Med; 2020 Feb 15; 17(1):112-131. PubMed ID: 32296580
    [Abstract] [Full Text] [Related]

  • 5. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N.
    J Exp Clin Cancer Res; 2019 Jun 18; 38(1):266. PubMed ID: 31215502
    [Abstract] [Full Text] [Related]

  • 6. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide.
    Xu X, Zheng Y, Luo L, You Z, Chen H, Wang J, Zhang F, Liu Y, Ke Y.
    Cell Death Dis; 2024 May 06; 15(5):318. PubMed ID: 38710703
    [Abstract] [Full Text] [Related]

  • 7. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y, Li H, Yi D, Sun Y, Bai Y, Zhong S, Song Y, Zhao G, Chen Y.
    Mol Pharm; 2018 Nov 05; 15(11):4912-4925. PubMed ID: 30336060
    [Abstract] [Full Text] [Related]

  • 8. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.
    Munoz JL, Rodriguez-Cruz V, Ramkissoon SH, Ligon KL, Greco SJ, Rameshwar P.
    Oncotarget; 2015 Jan 20; 6(2):1190-201. PubMed ID: 25595896
    [Abstract] [Full Text] [Related]

  • 9. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J.
    Life Sci; 2019 Nov 01; 236():116917. PubMed ID: 31614149
    [Abstract] [Full Text] [Related]

  • 10. Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells.
    Munoz JL, Walker ND, Scotto KW, Rameshwar P.
    Cancer Lett; 2015 Oct 10; 367(1):69-75. PubMed ID: 26208431
    [Abstract] [Full Text] [Related]

  • 11. Silencing of ZFP36L2 increases sensitivity to temozolomide through G2/M cell cycle arrest and BAX mediated apoptosis in GBM cells.
    Che Mat MF, Mohamad Hanif EA, Abdul Murad NA, Ibrahim K, Harun R, Jamal R.
    Mol Biol Rep; 2021 Feb 10; 48(2):1493-1503. PubMed ID: 33590411
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.
    Zhou M, Sareddy GR, Li M, Liu J, Luo Y, Venkata PP, Viswanadhapalli S, Tekmal RR, Brenner A, Vadlamudi RK.
    Sci Rep; 2019 Apr 16; 9(1):6124. PubMed ID: 30992459
    [Abstract] [Full Text] [Related]

  • 13. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z, Wei X, Shen L, Zhu H, Zheng X.
    Cancer Sci; 2019 Jan 16; 110(1):389-400. PubMed ID: 30431207
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.
    Liang H, Chen Z, Sun L.
    Mol Carcinog; 2019 Aug 16; 58(8):1502-1511. PubMed ID: 31045274
    [Abstract] [Full Text] [Related]

  • 15. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A, Wei Z, Yan W, Yin J, Huang X, Zhou X, Li R, Shen F, Wu W, Wang X, You Y.
    Cancer Lett; 2018 Nov 01; 436():10-21. PubMed ID: 30102952
    [Abstract] [Full Text] [Related]

  • 16. Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.
    Tiek DM, Rone JD, Graham GT, Pannkuk EL, Haddad BR, Riggins RB.
    Sci Rep; 2018 May 08; 8(1):7222. PubMed ID: 29740146
    [Abstract] [Full Text] [Related]

  • 17. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W, Yan D, Song Z, Zhu X, Liu X, Li X, Zhao S.
    Life Sci; 2019 Jun 01; 226():98-106. PubMed ID: 30980849
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S, Takahashi K, Wang L, Tanino M, Kimura T, Nishihara H, Tanaka S.
    Cancer Lett; 2013 Apr 30; 331(1):68-75. PubMed ID: 23246370
    [Abstract] [Full Text] [Related]

  • 19. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.
    Kim SS, Rait A, Kim E, Pirollo KF, Chang EH.
    Nanomedicine; 2015 Feb 30; 11(2):301-11. PubMed ID: 25240597
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C, Guo R, Guan F, Ma S, Li M, Wu J, Liu X, Li H, Yang B.
    Sci Rep; 2020 Jun 11; 10(1):9471. PubMed ID: 32528036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.